Lewes, DE -- (SBWIRE) -- 09/25/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO), Smith & Wesson Holding Corp (NASDAQ:SWHC), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Fifth Street Finance Corp. (NASDAQ:FSC).
JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO), increased1.74% and closed at $8.75 on a traded volume of 2.26 million shares, in comparison to 2.34 million shares of average trading volume. So far this year, the stock is up over 104.92%.
The company has a total market capitalization of $70.78 million and its total outstanding shares are 8.09million.
Will JASO Continue To Move Higher? Find Out Here
JA Solar Holdings Co., Ltd., through its subsidiaries, engages in the design, development, production, marketing, and sale of solar power products based on crystalline silicon technologies.
Smith & Wesson Holding Corp (NASDAQ:SWHC), closed at $11.60 on a traded volume of 2.20 million shares, whereas its average trading volume is 2.66 million shares. In the last three months, the stock is up20.46%. The Intra-day range for the stock is $11.38 and $11.97.
Will SWHC Continue To Move Higher? Find Out Here
Smith & Wesson Holding Corporation engages in the manufacture and sale of firearm products in the United States and internationally.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), dropped down -1.00% and closed at $19.81. So far in three months, the stock is up 20.94%. The 52-week range for the stock is $15.35 and $25.40 and during the previous trading session it marked$20.14 as its highest price. The stock initially exchanged hands with a price of $19.82 and the overall traded volume that day was 2.14 million shares.
Has ARIA Found The Bottom And Ready To Gain Momentum? Find Out Here
ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. The company focuses on commercializing Iclusig (ponatinib), a cancer medicine; and developing additional molecularly targeted therapies to treat patients with blood cancers and solid tumors.
Fifth Street Finance Corp. (NASDAQ:FSC) after opening its shares at the price of $10.28, dropped -0.10% to close the day at $10.29. The stock ended on a traded volume of 2.12 million shares, in comparison to 1.56 million shares of average trading volume. The 52-week range for the stock is $9.66 and $11.13 and during the previous trading session the stock scored the highest price of $10.32. It started the day at $10.28.
Will FSC Get Buyers Even After The Recent Rally? Find Out Here
Fifth Street Finance Corp. is a business development company specializing in investments in middle market, bridge financing, first and second lien debt financing, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, and management buyouts in small and mid-sized companies.
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)